Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-initiating Cells in C/EBPα Mutant AML

被引:141
作者
Bereshchenko, Oxana [1 ]
Mancini, Elena [1 ]
Moore, Susan [1 ]
Bilbao, Daniel [1 ]
Mansson, Robert [2 ]
Luc, Sidinh [3 ]
Grover, Amit [1 ]
Jacobsen, Sten Eirik W. [3 ]
Bryder, David [2 ]
Nerlov, Claus [1 ,4 ]
机构
[1] EMBL Mouse Biol Unit, I-00015 Monterotondo, Italy
[2] Lund Univ, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden
[3] Univ Oxford, Weatherall Inst Mol Med, Haemopoiet Stem Cell Lab, Oxford, England
[4] Univ Edinburgh, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland
基金
瑞典研究理事会;
关键词
BONE-MARROW SAMPLES; MULTIPOTENT PROGENITORS; GENE-EXPRESSION; RELAPSE SAMPLES; FLT3; MUTATIONS; SELF-RENEWAL; MURINE MODEL; IN-VIVO; PROLIFERATION; LINEAGE;
D O I
10.1016/j.ccr.2009.09.036
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We here use knockin mutagenesis in the mouse to model the spectrum of acquired CEBPA mutations in human acute myeloid leukemia. We find that C-terminal C/EBP alpha mutations increase the proliferation of long-term hematopoietic stem cells (LT-HSCs) in a cell-intrinsic manner and override normal HSC homeostasis, leading to expansion of premalignant HSCs. However, such mutations impair myeloid programming of HSCs and block myeloid lineage commitment when homozygous. In contrast, N-terminal C/EBP alpha mutations are silent with regards to HSC expansion, but allow the formation of committed myeloid progenitors, the templates for leukemia-initiating cells. The combination of N- and C-terminal C/EBP alpha mutations incorporates both features, accelerating disease development and explaining the clinical prevalence of this configuration of CEBPA mutations.
引用
收藏
页码:390 / 400
页数:11
相关论文
共 36 条
[1]
Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential:: A revised road map for adult blood lineage commitment [J].
Adolfsson, J ;
Månsson, R ;
Buza-Vidas, N ;
Hultquist, A ;
Liuba, K ;
Jensen, CT ;
Bryder, D ;
Yang, LP ;
Borge, OJ ;
Thoren, LAM ;
Anderson, K ;
Sitnicka, E ;
Sasaki, Y ;
Sigvardsson, M ;
Jacobsen, SEW .
CELL, 2005, 121 (02) :295-306
[2]
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[3]
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[4]
Malignant transformation initiated by MII-AF9: Gene dosage and critical target cells [J].
Chen, Weili ;
Kumar, Ashish R. ;
Hudson, Wendy A. ;
Li, Quanzhi ;
Wu, Baolin ;
Staggs, Rodney A. ;
Lund, Erik A. ;
Sam, Thien N. ;
Kersey, John H. .
CANCER CELL, 2008, 13 (05) :432-440
[5]
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors [J].
Cozzio, A ;
Passegué, E ;
Ayton, PM ;
Karsunky, H ;
Cleary, ML ;
Weissman, IL .
GENES & DEVELOPMENT, 2003, 17 (24) :3029-3035
[6]
Mutation of C/EBPα predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen [J].
Hasemann, Marie S. ;
Damgaard, Inge ;
Schuster, Mikkel B. ;
Theilgaard-Monch, Kim ;
Sorensen, Annette B. ;
Mrsic, Alan ;
Krugers, Thijs ;
Istra, Bauke Y. ;
Pedersen, Finn S. ;
Nerlov, Claus ;
Porse, Bo T. .
BLOOD, 2008, 111 (08) :4309-4321
[7]
C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo [J].
Heath, V ;
Suh, HC ;
Holman, M ;
Renn, K ;
Gooya, JM ;
Parkin, S ;
Klarmann, KD ;
Ortiz, M ;
Johnson, P ;
Keller, J .
BLOOD, 2004, 104 (06) :1639-1647
[8]
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia [J].
Higuchi, M ;
O'Brien, D ;
Kumaravelu, P ;
Lenny, N ;
Yeoh, EJ ;
Downing, JR .
CANCER CELL, 2002, 1 (01) :63-74
[9]
Multilineage gene expression precedes commitment in the hemopoietic system [J].
Hu, M ;
Krause, D ;
Greaves, M ;
Sharkis, S ;
Dexter, M ;
Heyworth, C ;
Enver, T .
GENES & DEVELOPMENT, 1997, 11 (06) :774-785
[10]
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors [J].
Huntly, BJP ;
Shigematsu, H ;
Deguchi, K ;
Lee, BH ;
Mizuno, S ;
Duclos, N ;
Rowan, R ;
Amaral, S ;
Curley, D ;
Williams, IR ;
Akashi, K ;
Gilliland, DG .
CANCER CELL, 2004, 6 (06) :587-596